nodes	percent_of_prediction	percent_of_DWPC	metapath
Ezetimibe—ABCC2—epilepsy syndrome	0.132	0.444	CbGaD
Ezetimibe—ABCG2—epilepsy syndrome	0.117	0.393	CbGaD
Ezetimibe—UGT2B15—Valproic Acid—epilepsy syndrome	0.0667	0.145	CbGbCtD
Ezetimibe—UGT1A3—Lamotrigine—epilepsy syndrome	0.056	0.122	CbGbCtD
Ezetimibe—ABCB1—epilepsy syndrome	0.0487	0.163	CbGaD
Ezetimibe—UGT2B7—Carbamazepine—epilepsy syndrome	0.0348	0.0756	CbGbCtD
Ezetimibe—ABCC3—Phenobarbital—epilepsy syndrome	0.0322	0.07	CbGbCtD
Ezetimibe—ABCC2—Levetiracetam—epilepsy syndrome	0.0319	0.0692	CbGbCtD
Ezetimibe—UGT1A3—Valproic Acid—epilepsy syndrome	0.0288	0.0625	CbGbCtD
Ezetimibe—UGT1A1—Propofol—epilepsy syndrome	0.0252	0.0547	CbGbCtD
Ezetimibe—UGT2B7—Valproic Acid—epilepsy syndrome	0.0208	0.0452	CbGbCtD
Ezetimibe—ABCC2—Carbamazepine—epilepsy syndrome	0.0183	0.0398	CbGbCtD
Ezetimibe—ABCC2—Phenytoin—epilepsy syndrome	0.0164	0.0357	CbGbCtD
Ezetimibe—ABCC2—Phenobarbital—epilepsy syndrome	0.0146	0.0318	CbGbCtD
Ezetimibe—ABCB1—Levetiracetam—epilepsy syndrome	0.0104	0.0226	CbGbCtD
Ezetimibe—ABCB1—Clobazam—epilepsy syndrome	0.00721	0.0156	CbGbCtD
Ezetimibe—ABCB1—Lamotrigine—epilepsy syndrome	0.00694	0.0151	CbGbCtD
Ezetimibe—ABCB1—Carbamazepine—epilepsy syndrome	0.00597	0.013	CbGbCtD
Ezetimibe—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.0057	0.0124	CbGbCtD
Ezetimibe—ABCB1—Phenytoin—epilepsy syndrome	0.00536	0.0116	CbGbCtD
Ezetimibe—CYP3A4—Felbamate—epilepsy syndrome	0.0053	0.0115	CbGbCtD
Ezetimibe—CYP3A4—Trimethadione—epilepsy syndrome	0.0053	0.0115	CbGbCtD
Ezetimibe—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00498	0.0108	CbGbCtD
Ezetimibe—ABCB1—Phenobarbital—epilepsy syndrome	0.00477	0.0104	CbGbCtD
Ezetimibe—ABCB1—Midazolam—epilepsy syndrome	0.00471	0.0102	CbGbCtD
Ezetimibe—ABCB1—Diazepam—epilepsy syndrome	0.00453	0.00983	CbGbCtD
Ezetimibe—CYP3A4—Clonazepam—epilepsy syndrome	0.0045	0.00978	CbGbCtD
Ezetimibe—CYP3A4—Clobazam—epilepsy syndrome	0.00432	0.00937	CbGbCtD
Ezetimibe—CYP3A4—Rufinamide—epilepsy syndrome	0.00367	0.00797	CbGbCtD
Ezetimibe—CYP3A4—Carbamazepine—epilepsy syndrome	0.00358	0.00777	CbGbCtD
Ezetimibe—CYP3A4—Primidone—epilepsy syndrome	0.00334	0.00725	CbGbCtD
Ezetimibe—CYP3A4—Phenytoin—epilepsy syndrome	0.00321	0.00697	CbGbCtD
Ezetimibe—CYP3A4—Propofol—epilepsy syndrome	0.00299	0.0065	CbGbCtD
Ezetimibe—CYP3A4—Acetazolamide—epilepsy syndrome	0.00286	0.00621	CbGbCtD
Ezetimibe—CYP3A4—Phenobarbital—epilepsy syndrome	0.00286	0.00621	CbGbCtD
Ezetimibe—CYP3A4—Midazolam—epilepsy syndrome	0.00282	0.00612	CbGbCtD
Ezetimibe—CYP3A4—Diazepam—epilepsy syndrome	0.00271	0.00589	CbGbCtD
Ezetimibe—CYP3A4—Zonisamide—epilepsy syndrome	0.00265	0.00575	CbGbCtD
Ezetimibe—CYP3A4—Valproic Acid—epilepsy syndrome	0.00214	0.00464	CbGbCtD
Ezetimibe—CYP3A4—Topiramate—epilepsy syndrome	0.00193	0.00419	CbGbCtD
Ezetimibe—Flunarizine—CACNA1G—epilepsy syndrome	0.000661	0.19	CrCbGaD
Ezetimibe—Pimozide—CACNA1G—epilepsy syndrome	0.000609	0.175	CrCbGaD
Ezetimibe—Flunarizine—CACNA1H—epilepsy syndrome	0.000595	0.171	CrCbGaD
Ezetimibe—Pimozide—OPRM1—epilepsy syndrome	0.000262	0.0755	CrCbGaD
Ezetimibe—Fluspirilene—ADRA2A—epilepsy syndrome	0.000254	0.0729	CrCbGaD
Ezetimibe—Pimozide—CHRM2—epilepsy syndrome	0.000222	0.0639	CrCbGaD
Ezetimibe—Fluspirilene—SLC6A4—epilepsy syndrome	0.000193	0.0556	CrCbGaD
Ezetimibe—Fluspirilene—HTR2A—epilepsy syndrome	0.000149	0.0428	CrCbGaD
Ezetimibe—Pimozide—CYP2C19—epilepsy syndrome	0.000137	0.0394	CrCbGaD
Ezetimibe—Pimozide—HTR2A—epilepsy syndrome	0.000111	0.032	CrCbGaD
Ezetimibe—Flunarizine—CYP2D6—epilepsy syndrome	0.00011	0.0317	CrCbGaD
Ezetimibe—Pimozide—CYP2D6—epilepsy syndrome	0.000102	0.0292	CrCbGaD
Ezetimibe—Pimozide—ABCB1—epilepsy syndrome	7.26e-05	0.0209	CrCbGaD
Ezetimibe—Body temperature increased—Lamotrigine—epilepsy syndrome	5.79e-05	0.000377	CcSEcCtD
Ezetimibe—Dizziness—Diazepam—epilepsy syndrome	5.79e-05	0.000377	CcSEcCtD
Ezetimibe—Infection—Valproic Acid—epilepsy syndrome	5.79e-05	0.000377	CcSEcCtD
Ezetimibe—Rash—Fosphenytoin—epilepsy syndrome	5.76e-05	0.000375	CcSEcCtD
Ezetimibe—Dermatitis—Fosphenytoin—epilepsy syndrome	5.75e-05	0.000375	CcSEcCtD
Ezetimibe—Asthenia—Clonazepam—epilepsy syndrome	5.74e-05	0.000374	CcSEcCtD
Ezetimibe—Back pain—Gabapentin—epilepsy syndrome	5.72e-05	0.000373	CcSEcCtD
Ezetimibe—Headache—Fosphenytoin—epilepsy syndrome	5.72e-05	0.000372	CcSEcCtD
Ezetimibe—Hepatitis—Topiramate—epilepsy syndrome	5.72e-05	0.000372	CcSEcCtD
Ezetimibe—Nervous system disorder—Valproic Acid—epilepsy syndrome	5.71e-05	0.000372	CcSEcCtD
Ezetimibe—Thrombocytopenia—Valproic Acid—epilepsy syndrome	5.7e-05	0.000371	CcSEcCtD
Ezetimibe—Palpitations—Pregabalin—epilepsy syndrome	5.7e-05	0.000371	CcSEcCtD
Ezetimibe—Asthenia—Phenytoin—epilepsy syndrome	5.7e-05	0.000371	CcSEcCtD
Ezetimibe—Nausea—Midazolam—epilepsy syndrome	5.69e-05	0.000371	CcSEcCtD
Ezetimibe—Muscle spasms—Gabapentin—epilepsy syndrome	5.69e-05	0.00037	CcSEcCtD
Ezetimibe—Diarrhoea—Zonisamide—epilepsy syndrome	5.68e-05	0.00037	CcSEcCtD
Ezetimibe—Pharyngitis—Topiramate—epilepsy syndrome	5.67e-05	0.00037	CcSEcCtD
Ezetimibe—Asthenia—Oxcarbazepine—epilepsy syndrome	5.67e-05	0.000369	CcSEcCtD
Ezetimibe—Pruritus—Clonazepam—epilepsy syndrome	5.66e-05	0.000369	CcSEcCtD
Ezetimibe—Vomiting—Vigabatrin—epilepsy syndrome	5.66e-05	0.000369	CcSEcCtD
Ezetimibe—Skin disorder—Valproic Acid—epilepsy syndrome	5.66e-05	0.000368	CcSEcCtD
Ezetimibe—Oedema peripheral—Topiramate—epilepsy syndrome	5.63e-05	0.000367	CcSEcCtD
Ezetimibe—Cough—Pregabalin—epilepsy syndrome	5.63e-05	0.000367	CcSEcCtD
Ezetimibe—Pruritus—Phenytoin—epilepsy syndrome	5.62e-05	0.000366	CcSEcCtD
Ezetimibe—Connective tissue disorder—Topiramate—epilepsy syndrome	5.62e-05	0.000366	CcSEcCtD
Ezetimibe—Nausea—Levetiracetam—epilepsy syndrome	5.62e-05	0.000366	CcSEcCtD
Ezetimibe—Rash—Vigabatrin—epilepsy syndrome	5.61e-05	0.000365	CcSEcCtD
Ezetimibe—Dizziness—Felbamate—epilepsy syndrome	5.61e-05	0.000365	CcSEcCtD
Ezetimibe—Dermatitis—Vigabatrin—epilepsy syndrome	5.61e-05	0.000365	CcSEcCtD
Ezetimibe—Pruritus—Oxcarbazepine—epilepsy syndrome	5.59e-05	0.000364	CcSEcCtD
Ezetimibe—Hypersensitivity—Carbamazepine—epilepsy syndrome	5.59e-05	0.000364	CcSEcCtD
Ezetimibe—Headache—Vigabatrin—epilepsy syndrome	5.57e-05	0.000363	CcSEcCtD
Ezetimibe—Hypertension—Pregabalin—epilepsy syndrome	5.57e-05	0.000363	CcSEcCtD
Ezetimibe—Vomiting—Diazepam—epilepsy syndrome	5.57e-05	0.000363	CcSEcCtD
Ezetimibe—Rash—Diazepam—epilepsy syndrome	5.52e-05	0.00036	CcSEcCtD
Ezetimibe—Dermatitis—Diazepam—epilepsy syndrome	5.52e-05	0.000359	CcSEcCtD
Ezetimibe—Chest pain—Pregabalin—epilepsy syndrome	5.49e-05	0.000358	CcSEcCtD
Ezetimibe—Myalgia—Pregabalin—epilepsy syndrome	5.49e-05	0.000358	CcSEcCtD
Ezetimibe—Arthralgia—Pregabalin—epilepsy syndrome	5.49e-05	0.000358	CcSEcCtD
Ezetimibe—Ill-defined disorder—Gabapentin—epilepsy syndrome	5.49e-05	0.000358	CcSEcCtD
Ezetimibe—Dizziness—Zonisamide—epilepsy syndrome	5.49e-05	0.000357	CcSEcCtD
Ezetimibe—Headache—Diazepam—epilepsy syndrome	5.49e-05	0.000357	CcSEcCtD
Ezetimibe—Diarrhoea—Clonazepam—epilepsy syndrome	5.47e-05	0.000356	CcSEcCtD
Ezetimibe—Anaemia—Gabapentin—epilepsy syndrome	5.47e-05	0.000356	CcSEcCtD
Ezetimibe—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	5.46e-05	0.000355	CcSEcCtD
Ezetimibe—Asthenia—Carbamazepine—epilepsy syndrome	5.44e-05	0.000354	CcSEcCtD
Ezetimibe—Diarrhoea—Phenytoin—epilepsy syndrome	5.44e-05	0.000354	CcSEcCtD
Ezetimibe—Discomfort—Pregabalin—epilepsy syndrome	5.43e-05	0.000353	CcSEcCtD
Ezetimibe—Nausea—Fosphenytoin—epilepsy syndrome	5.42e-05	0.000353	CcSEcCtD
Ezetimibe—Diarrhoea—Oxcarbazepine—epilepsy syndrome	5.41e-05	0.000352	CcSEcCtD
Ezetimibe—Erythema multiforme—Topiramate—epilepsy syndrome	5.41e-05	0.000352	CcSEcCtD
Ezetimibe—Angioedema—Gabapentin—epilepsy syndrome	5.41e-05	0.000352	CcSEcCtD
Ezetimibe—Hypersensitivity—Lamotrigine—epilepsy syndrome	5.4e-05	0.000352	CcSEcCtD
Ezetimibe—Vomiting—Felbamate—epilepsy syndrome	5.39e-05	0.000351	CcSEcCtD
Ezetimibe—Dry mouth—Pregabalin—epilepsy syndrome	5.37e-05	0.00035	CcSEcCtD
Ezetimibe—Pruritus—Carbamazepine—epilepsy syndrome	5.37e-05	0.000349	CcSEcCtD
Ezetimibe—Rash—Felbamate—epilepsy syndrome	5.35e-05	0.000348	CcSEcCtD
Ezetimibe—Dermatitis—Felbamate—epilepsy syndrome	5.34e-05	0.000348	CcSEcCtD
Ezetimibe—Malaise—Gabapentin—epilepsy syndrome	5.34e-05	0.000348	CcSEcCtD
Ezetimibe—Headache—Felbamate—epilepsy syndrome	5.31e-05	0.000346	CcSEcCtD
Ezetimibe—Confusional state—Pregabalin—epilepsy syndrome	5.31e-05	0.000346	CcSEcCtD
Ezetimibe—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	5.31e-05	0.000346	CcSEcCtD
Ezetimibe—Flushing—Topiramate—epilepsy syndrome	5.31e-05	0.000346	CcSEcCtD
Ezetimibe—Dizziness—Clonazepam—epilepsy syndrome	5.29e-05	0.000345	CcSEcCtD
Ezetimibe—Nausea—Vigabatrin—epilepsy syndrome	5.29e-05	0.000344	CcSEcCtD
Ezetimibe—Vomiting—Zonisamide—epilepsy syndrome	5.28e-05	0.000344	CcSEcCtD
Ezetimibe—Insomnia—Valproic Acid—epilepsy syndrome	5.27e-05	0.000343	CcSEcCtD
Ezetimibe—Anaphylactic shock—Pregabalin—epilepsy syndrome	5.27e-05	0.000343	CcSEcCtD
Ezetimibe—Asthenia—Lamotrigine—epilepsy syndrome	5.26e-05	0.000343	CcSEcCtD
Ezetimibe—Dizziness—Phenytoin—epilepsy syndrome	5.25e-05	0.000342	CcSEcCtD
Ezetimibe—Rash—Zonisamide—epilepsy syndrome	5.23e-05	0.000341	CcSEcCtD
Ezetimibe—Infection—Pregabalin—epilepsy syndrome	5.23e-05	0.000341	CcSEcCtD
Ezetimibe—Paraesthesia—Valproic Acid—epilepsy syndrome	5.23e-05	0.000341	CcSEcCtD
Ezetimibe—Palpitations—Gabapentin—epilepsy syndrome	5.23e-05	0.000341	CcSEcCtD
Ezetimibe—Dermatitis—Zonisamide—epilepsy syndrome	5.23e-05	0.000341	CcSEcCtD
Ezetimibe—Dizziness—Oxcarbazepine—epilepsy syndrome	5.23e-05	0.00034	CcSEcCtD
Ezetimibe—Nausea—Diazepam—epilepsy syndrome	5.2e-05	0.000339	CcSEcCtD
Ezetimibe—Headache—Zonisamide—epilepsy syndrome	5.2e-05	0.000339	CcSEcCtD
Ezetimibe—Dyspnoea—Valproic Acid—epilepsy syndrome	5.19e-05	0.000338	CcSEcCtD
Ezetimibe—Diarrhoea—Carbamazepine—epilepsy syndrome	5.19e-05	0.000338	CcSEcCtD
Ezetimibe—Angiopathy—Topiramate—epilepsy syndrome	5.19e-05	0.000338	CcSEcCtD
Ezetimibe—Pruritus—Lamotrigine—epilepsy syndrome	5.19e-05	0.000338	CcSEcCtD
Ezetimibe—Immune system disorder—Topiramate—epilepsy syndrome	5.16e-05	0.000336	CcSEcCtD
Ezetimibe—Nervous system disorder—Pregabalin—epilepsy syndrome	5.16e-05	0.000336	CcSEcCtD
Ezetimibe—Cough—Gabapentin—epilepsy syndrome	5.16e-05	0.000336	CcSEcCtD
Ezetimibe—Thrombocytopenia—Pregabalin—epilepsy syndrome	5.16e-05	0.000336	CcSEcCtD
Ezetimibe—Mediastinal disorder—Topiramate—epilepsy syndrome	5.15e-05	0.000336	CcSEcCtD
Ezetimibe—Dyspepsia—Valproic Acid—epilepsy syndrome	5.13e-05	0.000334	CcSEcCtD
Ezetimibe—Skin disorder—Pregabalin—epilepsy syndrome	5.11e-05	0.000333	CcSEcCtD
Ezetimibe—Hypertension—Gabapentin—epilepsy syndrome	5.11e-05	0.000333	CcSEcCtD
Ezetimibe—Vomiting—Clonazepam—epilepsy syndrome	5.09e-05	0.000331	CcSEcCtD
Ezetimibe—Decreased appetite—Valproic Acid—epilepsy syndrome	5.06e-05	0.00033	CcSEcCtD
Ezetimibe—Alopecia—Topiramate—epilepsy syndrome	5.05e-05	0.000329	CcSEcCtD
Ezetimibe—Vomiting—Phenytoin—epilepsy syndrome	5.05e-05	0.000329	CcSEcCtD
Ezetimibe—Rash—Clonazepam—epilepsy syndrome	5.04e-05	0.000328	CcSEcCtD
Ezetimibe—Dermatitis—Clonazepam—epilepsy syndrome	5.04e-05	0.000328	CcSEcCtD
Ezetimibe—Myalgia—Gabapentin—epilepsy syndrome	5.04e-05	0.000328	CcSEcCtD
Ezetimibe—Arthralgia—Gabapentin—epilepsy syndrome	5.04e-05	0.000328	CcSEcCtD
Ezetimibe—Chest pain—Gabapentin—epilepsy syndrome	5.04e-05	0.000328	CcSEcCtD
Ezetimibe—Nausea—Felbamate—epilepsy syndrome	5.04e-05	0.000328	CcSEcCtD
Ezetimibe—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	5.03e-05	0.000328	CcSEcCtD
Ezetimibe—Vomiting—Oxcarbazepine—epilepsy syndrome	5.03e-05	0.000327	CcSEcCtD
Ezetimibe—Fatigue—Valproic Acid—epilepsy syndrome	5.02e-05	0.000327	CcSEcCtD
Ezetimibe—Dizziness—Carbamazepine—epilepsy syndrome	5.02e-05	0.000327	CcSEcCtD
Ezetimibe—Diarrhoea—Lamotrigine—epilepsy syndrome	5.02e-05	0.000327	CcSEcCtD
Ezetimibe—Headache—Clonazepam—epilepsy syndrome	5.01e-05	0.000326	CcSEcCtD
Ezetimibe—Rash—Phenytoin—epilepsy syndrome	5.01e-05	0.000326	CcSEcCtD
Ezetimibe—Mental disorder—Topiramate—epilepsy syndrome	5.01e-05	0.000326	CcSEcCtD
Ezetimibe—Dermatitis—Phenytoin—epilepsy syndrome	5.01e-05	0.000326	CcSEcCtD
Ezetimibe—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	5e-05	0.000326	CcSEcCtD
Ezetimibe—Rash—Oxcarbazepine—epilepsy syndrome	4.98e-05	0.000325	CcSEcCtD
Ezetimibe—Pain—Valproic Acid—epilepsy syndrome	4.98e-05	0.000324	CcSEcCtD
Ezetimibe—Constipation—Valproic Acid—epilepsy syndrome	4.98e-05	0.000324	CcSEcCtD
Ezetimibe—Dermatitis—Oxcarbazepine—epilepsy syndrome	4.98e-05	0.000324	CcSEcCtD
Ezetimibe—Headache—Phenytoin—epilepsy syndrome	4.98e-05	0.000324	CcSEcCtD
Ezetimibe—Erythema—Topiramate—epilepsy syndrome	4.98e-05	0.000324	CcSEcCtD
Ezetimibe—Malnutrition—Topiramate—epilepsy syndrome	4.98e-05	0.000324	CcSEcCtD
Ezetimibe—Discomfort—Gabapentin—epilepsy syndrome	4.98e-05	0.000324	CcSEcCtD
Ezetimibe—Headache—Oxcarbazepine—epilepsy syndrome	4.95e-05	0.000322	CcSEcCtD
Ezetimibe—Nausea—Zonisamide—epilepsy syndrome	4.93e-05	0.000321	CcSEcCtD
Ezetimibe—Dry mouth—Gabapentin—epilepsy syndrome	4.93e-05	0.000321	CcSEcCtD
Ezetimibe—Flatulence—Topiramate—epilepsy syndrome	4.9e-05	0.000319	CcSEcCtD
Ezetimibe—Confusional state—Gabapentin—epilepsy syndrome	4.87e-05	0.000317	CcSEcCtD
Ezetimibe—Dizziness—Lamotrigine—epilepsy syndrome	4.85e-05	0.000316	CcSEcCtD
Ezetimibe—Anaphylactic shock—Gabapentin—epilepsy syndrome	4.83e-05	0.000314	CcSEcCtD
Ezetimibe—Vomiting—Carbamazepine—epilepsy syndrome	4.82e-05	0.000314	CcSEcCtD
Ezetimibe—Back pain—Topiramate—epilepsy syndrome	4.81e-05	0.000314	CcSEcCtD
Ezetimibe—Feeling abnormal—Valproic Acid—epilepsy syndrome	4.8e-05	0.000313	CcSEcCtD
Ezetimibe—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	4.8e-05	0.000312	CcSEcCtD
Ezetimibe—Infection—Gabapentin—epilepsy syndrome	4.8e-05	0.000312	CcSEcCtD
Ezetimibe—Muscle spasms—Topiramate—epilepsy syndrome	4.79e-05	0.000312	CcSEcCtD
Ezetimibe—Rash—Carbamazepine—epilepsy syndrome	4.78e-05	0.000311	CcSEcCtD
Ezetimibe—Dermatitis—Carbamazepine—epilepsy syndrome	4.78e-05	0.000311	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	4.76e-05	0.00031	CcSEcCtD
Ezetimibe—Insomnia—Pregabalin—epilepsy syndrome	4.76e-05	0.00031	CcSEcCtD
Ezetimibe—Nausea—Clonazepam—epilepsy syndrome	4.75e-05	0.000309	CcSEcCtD
Ezetimibe—Headache—Carbamazepine—epilepsy syndrome	4.75e-05	0.000309	CcSEcCtD
Ezetimibe—Nervous system disorder—Gabapentin—epilepsy syndrome	4.74e-05	0.000308	CcSEcCtD
Ezetimibe—Paraesthesia—Pregabalin—epilepsy syndrome	4.73e-05	0.000308	CcSEcCtD
Ezetimibe—Thrombocytopenia—Gabapentin—epilepsy syndrome	4.73e-05	0.000308	CcSEcCtD
Ezetimibe—Nausea—Phenytoin—epilepsy syndrome	4.72e-05	0.000307	CcSEcCtD
Ezetimibe—Dyspnoea—Pregabalin—epilepsy syndrome	4.69e-05	0.000306	CcSEcCtD
Ezetimibe—Nausea—Oxcarbazepine—epilepsy syndrome	4.69e-05	0.000306	CcSEcCtD
Ezetimibe—Skin disorder—Gabapentin—epilepsy syndrome	4.69e-05	0.000305	CcSEcCtD
Ezetimibe—Vomiting—Lamotrigine—epilepsy syndrome	4.66e-05	0.000304	CcSEcCtD
Ezetimibe—Urticaria—Valproic Acid—epilepsy syndrome	4.63e-05	0.000301	CcSEcCtD
Ezetimibe—Rash—Lamotrigine—epilepsy syndrome	4.62e-05	0.000301	CcSEcCtD
Ezetimibe—Ill-defined disorder—Topiramate—epilepsy syndrome	4.62e-05	0.000301	CcSEcCtD
Ezetimibe—Dermatitis—Lamotrigine—epilepsy syndrome	4.62e-05	0.000301	CcSEcCtD
Ezetimibe—Abdominal pain—Valproic Acid—epilepsy syndrome	4.6e-05	0.0003	CcSEcCtD
Ezetimibe—Body temperature increased—Valproic Acid—epilepsy syndrome	4.6e-05	0.0003	CcSEcCtD
Ezetimibe—Anaemia—Topiramate—epilepsy syndrome	4.6e-05	0.0003	CcSEcCtD
Ezetimibe—Headache—Lamotrigine—epilepsy syndrome	4.59e-05	0.000299	CcSEcCtD
Ezetimibe—Decreased appetite—Pregabalin—epilepsy syndrome	4.58e-05	0.000298	CcSEcCtD
Ezetimibe—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	4.55e-05	0.000296	CcSEcCtD
Ezetimibe—Fatigue—Pregabalin—epilepsy syndrome	4.54e-05	0.000296	CcSEcCtD
Ezetimibe—Nausea—Carbamazepine—epilepsy syndrome	4.5e-05	0.000293	CcSEcCtD
Ezetimibe—Pain—Pregabalin—epilepsy syndrome	4.5e-05	0.000293	CcSEcCtD
Ezetimibe—Constipation—Pregabalin—epilepsy syndrome	4.5e-05	0.000293	CcSEcCtD
Ezetimibe—Malaise—Topiramate—epilepsy syndrome	4.49e-05	0.000292	CcSEcCtD
Ezetimibe—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	4.4e-05	0.000287	CcSEcCtD
Ezetimibe—Palpitations—Topiramate—epilepsy syndrome	4.4e-05	0.000286	CcSEcCtD
Ezetimibe—Insomnia—Gabapentin—epilepsy syndrome	4.37e-05	0.000284	CcSEcCtD
Ezetimibe—Nausea—Lamotrigine—epilepsy syndrome	4.35e-05	0.000284	CcSEcCtD
Ezetimibe—Cough—Topiramate—epilepsy syndrome	4.34e-05	0.000283	CcSEcCtD
Ezetimibe—Feeling abnormal—Pregabalin—epilepsy syndrome	4.34e-05	0.000283	CcSEcCtD
Ezetimibe—Paraesthesia—Gabapentin—epilepsy syndrome	4.34e-05	0.000282	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Pregabalin—epilepsy syndrome	4.31e-05	0.00028	CcSEcCtD
Ezetimibe—Dyspnoea—Gabapentin—epilepsy syndrome	4.3e-05	0.00028	CcSEcCtD
Ezetimibe—Hypertension—Topiramate—epilepsy syndrome	4.3e-05	0.00028	CcSEcCtD
Ezetimibe—Hypersensitivity—Valproic Acid—epilepsy syndrome	4.29e-05	0.00028	CcSEcCtD
Ezetimibe—Dyspepsia—Gabapentin—epilepsy syndrome	4.25e-05	0.000277	CcSEcCtD
Ezetimibe—Myalgia—Topiramate—epilepsy syndrome	4.24e-05	0.000276	CcSEcCtD
Ezetimibe—Arthralgia—Topiramate—epilepsy syndrome	4.24e-05	0.000276	CcSEcCtD
Ezetimibe—Chest pain—Topiramate—epilepsy syndrome	4.24e-05	0.000276	CcSEcCtD
Ezetimibe—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	4.21e-05	0.000274	CcSEcCtD
Ezetimibe—Decreased appetite—Gabapentin—epilepsy syndrome	4.2e-05	0.000273	CcSEcCtD
Ezetimibe—Discomfort—Topiramate—epilepsy syndrome	4.19e-05	0.000273	CcSEcCtD
Ezetimibe—Urticaria—Pregabalin—epilepsy syndrome	4.18e-05	0.000272	CcSEcCtD
Ezetimibe—Asthenia—Valproic Acid—epilepsy syndrome	4.18e-05	0.000272	CcSEcCtD
Ezetimibe—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	4.17e-05	0.000272	CcSEcCtD
Ezetimibe—Fatigue—Gabapentin—epilepsy syndrome	4.16e-05	0.000271	CcSEcCtD
Ezetimibe—Body temperature increased—Pregabalin—epilepsy syndrome	4.16e-05	0.000271	CcSEcCtD
Ezetimibe—Abdominal pain—Pregabalin—epilepsy syndrome	4.16e-05	0.000271	CcSEcCtD
Ezetimibe—Dry mouth—Topiramate—epilepsy syndrome	4.14e-05	0.00027	CcSEcCtD
Ezetimibe—Pain—Gabapentin—epilepsy syndrome	4.13e-05	0.000269	CcSEcCtD
Ezetimibe—Constipation—Gabapentin—epilepsy syndrome	4.13e-05	0.000269	CcSEcCtD
Ezetimibe—Pruritus—Valproic Acid—epilepsy syndrome	4.12e-05	0.000268	CcSEcCtD
Ezetimibe—Confusional state—Topiramate—epilepsy syndrome	4.1e-05	0.000267	CcSEcCtD
Ezetimibe—Infection—Topiramate—epilepsy syndrome	4.04e-05	0.000263	CcSEcCtD
Ezetimibe—Diarrhoea—Valproic Acid—epilepsy syndrome	3.99e-05	0.00026	CcSEcCtD
Ezetimibe—Nervous system disorder—Topiramate—epilepsy syndrome	3.98e-05	0.000259	CcSEcCtD
Ezetimibe—Feeling abnormal—Gabapentin—epilepsy syndrome	3.98e-05	0.000259	CcSEcCtD
Ezetimibe—Thrombocytopenia—Topiramate—epilepsy syndrome	3.98e-05	0.000259	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Gabapentin—epilepsy syndrome	3.95e-05	0.000257	CcSEcCtD
Ezetimibe—Skin disorder—Topiramate—epilepsy syndrome	3.95e-05	0.000257	CcSEcCtD
Ezetimibe—Hypersensitivity—Pregabalin—epilepsy syndrome	3.88e-05	0.000253	CcSEcCtD
Ezetimibe—Dizziness—Valproic Acid—epilepsy syndrome	3.85e-05	0.000251	CcSEcCtD
Ezetimibe—Urticaria—Gabapentin—epilepsy syndrome	3.84e-05	0.00025	CcSEcCtD
Ezetimibe—Abdominal pain—Gabapentin—epilepsy syndrome	3.82e-05	0.000249	CcSEcCtD
Ezetimibe—Body temperature increased—Gabapentin—epilepsy syndrome	3.82e-05	0.000249	CcSEcCtD
Ezetimibe—Asthenia—Pregabalin—epilepsy syndrome	3.78e-05	0.000246	CcSEcCtD
Ezetimibe—Pruritus—Pregabalin—epilepsy syndrome	3.73e-05	0.000243	CcSEcCtD
Ezetimibe—Vomiting—Valproic Acid—epilepsy syndrome	3.7e-05	0.000241	CcSEcCtD
Ezetimibe—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	3.7e-05	0.000241	CcSEcCtD
Ezetimibe—Insomnia—Topiramate—epilepsy syndrome	3.67e-05	0.000239	CcSEcCtD
Ezetimibe—Rash—Valproic Acid—epilepsy syndrome	3.67e-05	0.000239	CcSEcCtD
Ezetimibe—Dermatitis—Valproic Acid—epilepsy syndrome	3.67e-05	0.000239	CcSEcCtD
Ezetimibe—Headache—Valproic Acid—epilepsy syndrome	3.65e-05	0.000238	CcSEcCtD
Ezetimibe—Paraesthesia—Topiramate—epilepsy syndrome	3.65e-05	0.000238	CcSEcCtD
Ezetimibe—Dyspnoea—Topiramate—epilepsy syndrome	3.62e-05	0.000236	CcSEcCtD
Ezetimibe—Diarrhoea—Pregabalin—epilepsy syndrome	3.6e-05	0.000235	CcSEcCtD
Ezetimibe—Dyspepsia—Topiramate—epilepsy syndrome	3.58e-05	0.000233	CcSEcCtD
Ezetimibe—Hypersensitivity—Gabapentin—epilepsy syndrome	3.56e-05	0.000232	CcSEcCtD
Ezetimibe—Decreased appetite—Topiramate—epilepsy syndrome	3.53e-05	0.00023	CcSEcCtD
Ezetimibe—Gastrointestinal disorder—Topiramate—epilepsy syndrome	3.51e-05	0.000228	CcSEcCtD
Ezetimibe—Fatigue—Topiramate—epilepsy syndrome	3.5e-05	0.000228	CcSEcCtD
Ezetimibe—Dizziness—Pregabalin—epilepsy syndrome	3.48e-05	0.000227	CcSEcCtD
Ezetimibe—Constipation—Topiramate—epilepsy syndrome	3.47e-05	0.000226	CcSEcCtD
Ezetimibe—Pain—Topiramate—epilepsy syndrome	3.47e-05	0.000226	CcSEcCtD
Ezetimibe—Asthenia—Gabapentin—epilepsy syndrome	3.46e-05	0.000226	CcSEcCtD
Ezetimibe—Nausea—Valproic Acid—epilepsy syndrome	3.46e-05	0.000225	CcSEcCtD
Ezetimibe—Pruritus—Gabapentin—epilepsy syndrome	3.42e-05	0.000223	CcSEcCtD
Ezetimibe—Vomiting—Pregabalin—epilepsy syndrome	3.35e-05	0.000218	CcSEcCtD
Ezetimibe—Feeling abnormal—Topiramate—epilepsy syndrome	3.35e-05	0.000218	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Topiramate—epilepsy syndrome	3.32e-05	0.000216	CcSEcCtD
Ezetimibe—Rash—Pregabalin—epilepsy syndrome	3.32e-05	0.000216	CcSEcCtD
Ezetimibe—Dermatitis—Pregabalin—epilepsy syndrome	3.32e-05	0.000216	CcSEcCtD
Ezetimibe—Diarrhoea—Gabapentin—epilepsy syndrome	3.3e-05	0.000215	CcSEcCtD
Ezetimibe—Headache—Pregabalin—epilepsy syndrome	3.3e-05	0.000215	CcSEcCtD
Ezetimibe—Urticaria—Topiramate—epilepsy syndrome	3.23e-05	0.00021	CcSEcCtD
Ezetimibe—Body temperature increased—Topiramate—epilepsy syndrome	3.21e-05	0.000209	CcSEcCtD
Ezetimibe—Abdominal pain—Topiramate—epilepsy syndrome	3.21e-05	0.000209	CcSEcCtD
Ezetimibe—Dizziness—Gabapentin—epilepsy syndrome	3.19e-05	0.000208	CcSEcCtD
Ezetimibe—Nausea—Pregabalin—epilepsy syndrome	3.13e-05	0.000204	CcSEcCtD
Ezetimibe—Vomiting—Gabapentin—epilepsy syndrome	3.07e-05	0.0002	CcSEcCtD
Ezetimibe—Rash—Gabapentin—epilepsy syndrome	3.04e-05	0.000198	CcSEcCtD
Ezetimibe—Dermatitis—Gabapentin—epilepsy syndrome	3.04e-05	0.000198	CcSEcCtD
Ezetimibe—Headache—Gabapentin—epilepsy syndrome	3.02e-05	0.000197	CcSEcCtD
Ezetimibe—Hypersensitivity—Topiramate—epilepsy syndrome	2.99e-05	0.000195	CcSEcCtD
Ezetimibe—Asthenia—Topiramate—epilepsy syndrome	2.91e-05	0.00019	CcSEcCtD
Ezetimibe—Pruritus—Topiramate—epilepsy syndrome	2.87e-05	0.000187	CcSEcCtD
Ezetimibe—Nausea—Gabapentin—epilepsy syndrome	2.87e-05	0.000187	CcSEcCtD
Ezetimibe—Diarrhoea—Topiramate—epilepsy syndrome	2.78e-05	0.000181	CcSEcCtD
Ezetimibe—Dizziness—Topiramate—epilepsy syndrome	2.69e-05	0.000175	CcSEcCtD
Ezetimibe—Vomiting—Topiramate—epilepsy syndrome	2.58e-05	0.000168	CcSEcCtD
Ezetimibe—Rash—Topiramate—epilepsy syndrome	2.56e-05	0.000167	CcSEcCtD
Ezetimibe—Dermatitis—Topiramate—epilepsy syndrome	2.56e-05	0.000167	CcSEcCtD
Ezetimibe—Headache—Topiramate—epilepsy syndrome	2.54e-05	0.000166	CcSEcCtD
Ezetimibe—Nausea—Topiramate—epilepsy syndrome	2.41e-05	0.000157	CcSEcCtD
Ezetimibe—ABCB1—Allograft Rejection—TNF—epilepsy syndrome	7.8e-06	9.28e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—CA4—epilepsy syndrome	7.8e-06	9.28e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—QDPR—epilepsy syndrome	7.8e-06	9.28e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	7.8e-06	9.28e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—AQP1—epilepsy syndrome	7.79e-06	9.27e-05	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—SLC2A1—epilepsy syndrome	7.74e-06	9.21e-05	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—PLCB1—epilepsy syndrome	7.66e-06	9.11e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	7.65e-06	9.11e-05	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—TH—epilepsy syndrome	7.63e-06	9.08e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—KCNJ11—epilepsy syndrome	7.61e-06	9.05e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—CHRM3—epilepsy syndrome	7.61e-06	9.05e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—CA13—epilepsy syndrome	7.46e-06	8.87e-05	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—AKT1—epilepsy syndrome	7.36e-06	8.75e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—COX3—epilepsy syndrome	7.33e-06	8.73e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	7.3e-06	8.69e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—CYP2D6—epilepsy syndrome	7.28e-06	8.66e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—CYP2D6—epilepsy syndrome	7.28e-06	8.66e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	7.25e-06	8.63e-05	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—ALB—epilepsy syndrome	7.14e-06	8.5e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	7.09e-06	8.43e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—CHRM3—epilepsy syndrome	7.05e-06	8.38e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—KCNJ11—epilepsy syndrome	7.05e-06	8.38e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—epilepsy syndrome	7e-06	8.32e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—SLCO1A2—epilepsy syndrome	6.95e-06	8.27e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—KCNB1—epilepsy syndrome	6.95e-06	8.27e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—CACNA2D2—epilepsy syndrome	6.95e-06	8.27e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—PFKL—epilepsy syndrome	6.95e-06	8.27e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—SLC6A8—epilepsy syndrome	6.95e-06	8.27e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Transmembrane transport of small molecules—ALB—epilepsy syndrome	6.94e-06	8.26e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	6.94e-06	8.26e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—ADRA2A—epilepsy syndrome	6.93e-06	8.25e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—ADRA2A—epilepsy syndrome	6.93e-06	8.25e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—BCHE—epilepsy syndrome	6.9e-06	8.21e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—BCHE—epilepsy syndrome	6.9e-06	8.21e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—ABCG2—epilepsy syndrome	6.77e-06	8.05e-05	CbGpPWpGaD
Ezetimibe—ABCB1—HIF-1-alpha transcription factor network—AKT1—epilepsy syndrome	6.71e-06	7.98e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	6.63e-06	7.89e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—CYP2C19—epilepsy syndrome	6.6e-06	7.85e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—SLC2A1—epilepsy syndrome	6.59e-06	7.83e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—SLC2A1—epilepsy syndrome	6.59e-06	7.83e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—CYP11A1—epilepsy syndrome	6.56e-06	7.8e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—PLCB1—epilepsy syndrome	6.51e-06	7.75e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—PLCB1—epilepsy syndrome	6.51e-06	7.75e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—TH—epilepsy syndrome	6.49e-06	7.72e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—TH—epilepsy syndrome	6.49e-06	7.72e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	6.46e-06	7.69e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	6.39e-06	7.6e-05	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—HMOX1—epilepsy syndrome	6.37e-06	7.58e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—UPB1—epilepsy syndrome	6.36e-06	7.57e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—ATIC—epilepsy syndrome	6.36e-06	7.57e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—NEU1—epilepsy syndrome	6.36e-06	7.57e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—epilepsy syndrome	6.32e-06	7.52e-05	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—CAT—epilepsy syndrome	6.29e-06	7.48e-05	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—PTGS2—epilepsy syndrome	6.25e-06	7.43e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—ABCG2—epilepsy syndrome	6.2e-06	7.38e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—HSD17B4—epilepsy syndrome	6.12e-06	7.28e-05	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—ABCB1—epilepsy syndrome	6.11e-06	7.27e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—CYP2C19—epilepsy syndrome	6.05e-06	7.19e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—CYP11A1—epilepsy syndrome	6.01e-06	7.15e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—epilepsy syndrome	6e-06	7.14e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	5.96e-06	7.1e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—CYP2D6—epilepsy syndrome	5.92e-06	7.04e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—GBE1—epilepsy syndrome	5.91e-06	7.03e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—PPP1R3C—epilepsy syndrome	5.91e-06	7.03e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—epilepsy syndrome	5.7e-06	6.79e-05	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—GPX1—epilepsy syndrome	5.68e-06	6.76e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—GLUD1—epilepsy syndrome	5.65e-06	6.72e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—L2HGDH—epilepsy syndrome	5.65e-06	6.72e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—ADK—epilepsy syndrome	5.65e-06	6.72e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PDXK—epilepsy syndrome	5.65e-06	6.72e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—FAR1—epilepsy syndrome	5.65e-06	6.72e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—CERS1—epilepsy syndrome	5.65e-06	6.72e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—ADRA2A—epilepsy syndrome	5.63e-06	6.7e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—BCHE—epilepsy syndrome	5.61e-06	6.67e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—CYP2C19—epilepsy syndrome	5.6e-06	6.66e-05	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—AKT1—epilepsy syndrome	5.57e-06	6.63e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—CYP11A1—epilepsy syndrome	5.56e-06	6.62e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—ASAH1—epilepsy syndrome	5.56e-06	6.61e-05	CbGpPWpGaD
Ezetimibe—ABCC2—Transmembrane transport of small molecules—ALB—epilepsy syndrome	5.51e-06	6.55e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	5.49e-06	6.54e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	5.44e-06	6.47e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—CYP2D6—epilepsy syndrome	5.42e-06	6.45e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—HMOX1—epilepsy syndrome	5.42e-06	6.44e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—HMOX1—epilepsy syndrome	5.42e-06	6.44e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—STXBP1—epilepsy syndrome	5.41e-06	6.43e-05	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—AKT1—epilepsy syndrome	5.37e-06	6.38e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—SLC2A1—epilepsy syndrome	5.35e-06	6.37e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—CAT—epilepsy syndrome	5.34e-06	6.36e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—CAT—epilepsy syndrome	5.34e-06	6.36e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—epilepsy syndrome	5.29e-06	6.3e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—PLCB1—epilepsy syndrome	5.29e-06	6.3e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—TH—epilepsy syndrome	5.27e-06	6.27e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—NT5E—epilepsy syndrome	5.27e-06	6.27e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—ALAD—epilepsy syndrome	5.27e-06	6.27e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	5.24e-06	6.24e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—ABCB1—epilepsy syndrome	5.2e-06	6.19e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—ABCB1—epilepsy syndrome	5.2e-06	6.19e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	5.17e-06	6.15e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—GAMT—epilepsy syndrome	5.17e-06	6.15e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PNPO—epilepsy syndrome	5.17e-06	6.15e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—NHLRC1—epilepsy syndrome	5.17e-06	6.15e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—EPM2A—epilepsy syndrome	5.17e-06	6.15e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—ADRA2A—epilepsy syndrome	5.16e-06	6.14e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—epilepsy syndrome	5.14e-06	6.12e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—BCHE—epilepsy syndrome	5.14e-06	6.12e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—ALDH7A1—epilepsy syndrome	5.03e-06	5.98e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—CACNA1A—epilepsy syndrome	5.03e-06	5.98e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—CYP2D6—epilepsy syndrome	5.02e-06	5.97e-05	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—AGT—epilepsy syndrome	4.98e-06	5.93e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—ST3GAL3—epilepsy syndrome	4.92e-06	5.85e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—SLC2A1—epilepsy syndrome	4.9e-06	5.83e-05	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—APOE—epilepsy syndrome	4.88e-06	5.81e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—PLCB1—epilepsy syndrome	4.85e-06	5.77e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—GPX1—epilepsy syndrome	4.83e-06	5.75e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—GPX1—epilepsy syndrome	4.83e-06	5.75e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—TH—epilepsy syndrome	4.83e-06	5.75e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—ADSL—epilepsy syndrome	4.82e-06	5.73e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—CA4—epilepsy syndrome	4.81e-06	5.72e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—QDPR—epilepsy syndrome	4.81e-06	5.72e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	4.79e-06	5.7e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Transmembrane transport of small molecules—ALB—epilepsy syndrome	4.79e-06	5.7e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—ADRA2A—epilepsy syndrome	4.78e-06	5.69e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—BCHE—epilepsy syndrome	4.76e-06	5.66e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	4.76e-06	5.66e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—GLUL—epilepsy syndrome	4.73e-06	5.62e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—CACNA1D—epilepsy syndrome	4.64e-06	5.52e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—epilepsy syndrome	4.61e-06	5.49e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—SLC2A1—epilepsy syndrome	4.54e-06	5.4e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—COX3—epilepsy syndrome	4.52e-06	5.38e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—epilepsy syndrome	4.49e-06	5.35e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—PLCB1—epilepsy syndrome	4.49e-06	5.34e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—TH—epilepsy syndrome	4.47e-06	5.32e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—HMOX1—epilepsy syndrome	4.4e-06	5.24e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—CAT—epilepsy syndrome	4.34e-06	5.17e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—TXNRD1—epilepsy syndrome	4.34e-06	5.16e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	4.31e-06	5.13e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	4.28e-06	5.1e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	4.28e-06	5.1e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	4.28e-06	5.1e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PFKL—epilepsy syndrome	4.28e-06	5.1e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	4.28e-06	5.1e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—AVP—epilepsy syndrome	4.27e-06	5.08e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—AGT—epilepsy syndrome	4.24e-06	5.04e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—AGT—epilepsy syndrome	4.24e-06	5.04e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—ABCB1—epilepsy syndrome	4.22e-06	5.03e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—AQP1—epilepsy syndrome	4.21e-06	5.01e-05	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—POMC—epilepsy syndrome	4.2e-06	4.99e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—APOE—epilepsy syndrome	4.15e-06	4.94e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—APOE—epilepsy syndrome	4.15e-06	4.94e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—HMOX1—epilepsy syndrome	4.03e-06	4.8e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—CAT—epilepsy syndrome	3.98e-06	4.74e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—GPX1—epilepsy syndrome	3.93e-06	4.67e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—UPB1—epilepsy syndrome	3.92e-06	4.66e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—NEU1—epilepsy syndrome	3.92e-06	4.66e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—ATIC—epilepsy syndrome	3.92e-06	4.66e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—ABCB1—epilepsy syndrome	3.87e-06	4.61e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	3.85e-06	4.58e-05	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—ALB—epilepsy syndrome	3.83e-06	4.55e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—CHRM3—epilepsy syndrome	3.81e-06	4.53e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—KCNJ11—epilepsy syndrome	3.81e-06	4.53e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	3.77e-06	4.49e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—HMOX1—epilepsy syndrome	3.73e-06	4.44e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—CAT—epilepsy syndrome	3.69e-06	4.38e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	3.64e-06	4.33e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—GBE1—epilepsy syndrome	3.64e-06	4.33e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—GPX1—epilepsy syndrome	3.6e-06	4.28e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—ABCB1—epilepsy syndrome	3.58e-06	4.26e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—POMC—epilepsy syndrome	3.57e-06	4.24e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—POMC—epilepsy syndrome	3.57e-06	4.24e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—AGT—epilepsy syndrome	3.44e-06	4.1e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	3.42e-06	4.07e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—APOE—epilepsy syndrome	3.37e-06	4.01e-05	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—PTGS2—epilepsy syndrome	3.35e-06	3.98e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—GPX1—epilepsy syndrome	3.33e-06	3.97e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	3.33e-06	3.96e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—ALB—epilepsy syndrome	3.25e-06	3.87e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—ALB—epilepsy syndrome	3.25e-06	3.87e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—NT5E—epilepsy syndrome	3.25e-06	3.86e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—ALAD—epilepsy syndrome	3.25e-06	3.86e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—AGT—epilepsy syndrome	3.16e-06	3.75e-05	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—AKT1—epilepsy syndrome	3.14e-06	3.74e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—ABCG2—epilepsy syndrome	3.11e-06	3.69e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	3.1e-06	3.68e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	3.1e-06	3.68e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—APOE—epilepsy syndrome	3.09e-06	3.68e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	3.03e-06	3.61e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—CYP2C19—epilepsy syndrome	3.03e-06	3.6e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—CYP11A1—epilepsy syndrome	3.01e-06	3.58e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—ADSL—epilepsy syndrome	2.97e-06	3.53e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—AGT—epilepsy syndrome	2.92e-06	3.48e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—GLUL—epilepsy syndrome	2.91e-06	3.46e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—POMC—epilepsy syndrome	2.9e-06	3.45e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	2.87e-06	3.41e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—APOE—epilepsy syndrome	2.86e-06	3.41e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	2.86e-06	3.4e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—PTGS2—epilepsy syndrome	2.85e-06	3.39e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—PTGS2—epilepsy syndrome	2.85e-06	3.39e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—CYP2D6—epilepsy syndrome	2.71e-06	3.23e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	2.67e-06	3.18e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—POMC—epilepsy syndrome	2.66e-06	3.16e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—ALB—epilepsy syndrome	2.64e-06	3.14e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—AQP1—epilepsy syndrome	2.6e-06	3.09e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	2.59e-06	3.08e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—ADRA2A—epilepsy syndrome	2.58e-06	3.07e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—BCHE—epilepsy syndrome	2.57e-06	3.06e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—POMC—epilepsy syndrome	2.46e-06	2.93e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—SLC2A1—epilepsy syndrome	2.45e-06	2.92e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—PLCB1—epilepsy syndrome	2.43e-06	2.89e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—ALB—epilepsy syndrome	2.42e-06	2.88e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—TH—epilepsy syndrome	2.42e-06	2.88e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	2.35e-06	2.79e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	2.35e-06	2.79e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—PTGS2—epilepsy syndrome	2.31e-06	2.75e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—ALB—epilepsy syndrome	2.24e-06	2.67e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—PTGS2—epilepsy syndrome	2.12e-06	2.52e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—HMOX1—epilepsy syndrome	2.02e-06	2.4e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—CAT—epilepsy syndrome	1.99e-06	2.37e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—PTGS2—epilepsy syndrome	1.96e-06	2.33e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	1.91e-06	2.28e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	1.86e-06	2.22e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	1.85e-06	2.2e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—GPX1—epilepsy syndrome	1.8e-06	2.14e-05	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—AKT1—epilepsy syndrome	1.68e-06	2e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	1.67e-06	1.99e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	1.59e-06	1.89e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—BCHE—epilepsy syndrome	1.59e-06	1.89e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—AGT—epilepsy syndrome	1.58e-06	1.88e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—APOE—epilepsy syndrome	1.55e-06	1.84e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	1.51e-06	1.8e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	1.5e-06	1.78e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—TH—epilepsy syndrome	1.49e-06	1.77e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—AKT1—epilepsy syndrome	1.43e-06	1.7e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—AKT1—epilepsy syndrome	1.43e-06	1.7e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—POMC—epilepsy syndrome	1.33e-06	1.58e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	1.24e-06	1.48e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—CAT—epilepsy syndrome	1.23e-06	1.46e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—ALB—epilepsy syndrome	1.21e-06	1.44e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	1.19e-06	1.42e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—AKT1—epilepsy syndrome	1.16e-06	1.38e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—GPX1—epilepsy syndrome	1.11e-06	1.32e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—AKT1—epilepsy syndrome	1.06e-06	1.27e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—PTGS2—epilepsy syndrome	1.06e-06	1.26e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—AKT1—epilepsy syndrome	9.86e-07	1.17e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—AGT—epilepsy syndrome	9.73e-07	1.16e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—APOE—epilepsy syndrome	9.54e-07	1.13e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—POMC—epilepsy syndrome	8.19e-07	9.75e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—ALB—epilepsy syndrome	7.47e-07	8.89e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	6.54e-07	7.78e-06	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—AKT1—epilepsy syndrome	5.33e-07	6.34e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—AKT1—epilepsy syndrome	3.28e-07	3.91e-06	CbGpPWpGaD
